RG-6333 (Anti-CD19, Anti-CD28 Bispecific)

RG-6333 (Anti-CD19, Anti-CD28 Bispecific)
SKU
BPS83672-1
Packaging Unit
1 mg
Manufacturer
BPS Bioscience

Availability: loading...
Price is loading...
Products from BPS Bioscience require a minimum order value above 400€

Application: USeful for ELISA, flow cytometry and functional assays.

Background: B-lymphocyte antigen CD19 (Cluster of Differentiation 19), also known as B-Lymphocyte Surface Antigen B4 and CVID3, is a transmembrane protein expressed in follicular dendritic cells and all B lineage cells except plasma cells. CD19 plays two major roles in human B cells. It acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane and it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development and lymphoma diagnosis and can be used as a target for leukemia immunotherapies. CD19-targeted therapies based on T cells that express CD19-specific chimeric antigen receptors (CARs) have been utilized for their antitumor abilities in patients with CD19+ lymphoma and leukemia, such as Non-Hodgkins Lymphoma (NHL), CLL (chronic lymphocytic leukemia) and ALL (acute lymphoblastic leukemia). The T cell-specific receptor CD28 is an important regulator of the immune system. The ligation of CD28 and its ligands CD80/CD86 on the APC provides a critical costimulatory signal alongside T cell receptor (TCR) for T cell activation. The costimulatory signal can also be delivered by the interaction between CD28 and its agonist antibody. The use of bispecifics targeting these proteins can result in improved T cell cytotoxicity.

Description: RG-6333 is a bispecific agonist that targets CD19 and CD28. It specifically recognizes and binds to the CD19 antigen on the surface of B-cell malignancies to locate tumor cells. RG-6333 activates T cells by binding to CD28 overcoming activation barriers to enhance anti-tumor immunity.

Purity: ≥90%

Reconstitution: The product can be reconstituted/diluted with sterile PBS or saline.

Storage Stability: At least 6 months at -80°C.

Target: CD19, CD28

Uniprot: P11609 and P31041

Warnings: Avoid freeze/thaw cycles.

Biosafety Level: Not applicable (BSL-1)
More Information
SKU BPS83672-1
Manufacturer BPS Bioscience
Manufacturer SKU 83672-1
Package Unit 1 mg
Quantity Unit STK
Application ELISA
Isotype IgG4 kappa
Conjugate Unconjugated
Product information (PDF)
×
MSDS (PDF)
×